Revised EU GMP Annex I Contamination Control Strategy in Pharmaceutical industry l CCS in Pharma industry Question and answers
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Link to download :

[ Ссылка ]

Pick your favourite topic video from below playlist:

1. QMS - Quality Management System in Pharmaceutical industry : [ Ссылка ]
2. QA- Quality assurance in Pharmaceutical industry. : [ Ссылка ]
3. QC - Quality Control in Pharmaceutical industry :
[ Ссылка ]
4. OSD - Tablet Manufacturing in Pharmaceutical industry :
[ Ссылка ]
5. Injectable processing - Injectable processing or Sterile dosage formulation : [ Ссылка ]
-----------------------------------------------------------------------------------------------
Questions covered:

Q. When EU GMP Annex I has been updated or what are the deadline for coming into operation ?
Q. What is contamination control strategy as per revised EU GMP Annex I ?
Q. What is the scope of contamination control strategy given in EU GMP Annex I or where it is applicable ?
Q. Which two concepts are highlighted in the new version of Annex-I ?
Q. What are the key components that a Comprehensive Contamination Control Strategy (CCS) should include ?
Q. What is purpose of revision of Annex I with respect to contamination control strategy ?
Q. What elements needs to be considered for preparing CCS ?
Q. As per revised Annex I, what parameters and attributes should contamination control strategy include ?
Q. What is the limit as per revised EU GMP Annex I for Maximum permitted particle concentration and microbial contamination ?
Q. What key components comes under the consideration of Contamination control Strategy i.e. CCS ?
Q. What you will need to prepare proper contamination control strategy ?
-----------------------------------------------------------------------------------------------
Keywords to find this video:
contamination control strategy,contamination control,contamination control strategy in aseptic area,contamination,contamination control strategy annex 1,pharmaceuticals,validation in pharmaceutical industry,annex 1,pharmaceutical,voices in validation,pharmaceutical remediation,quality control,pharmaceutical consultants,us fda in pharmaceuticals,pharmaceutical courses,pharmaceutical legislation training,eu gmp annex 1,pharmaceutical training

-----------------------------------------------------------------------------------------------

Copyright disclaimer:
“Any illegal reproduction of this content will result in immediate legal action.”

свернуть